Back to Search
Start Over
[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
- Source :
-
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2011; Vol. 56 (7-8), pp. 42-6. - Publication Year :
- 2011
-
Abstract
- Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopinavir and ritonavir used in the SARS foci is confirmed. The drugs are at present applicable all over the world in retrovirus therapy of HIV infected subjects. The search for efficient Russian unspecific medicines for control of SARS is actual.
- Subjects :
- Antiviral Agents adverse effects
Drug Therapy, Combination
Humans
Lopinavir administration & dosage
Lopinavir adverse effects
Ribavirin administration & dosage
Ribavirin adverse effects
Ritonavir administration & dosage
Ritonavir adverse effects
Treatment Outcome
Antiviral Agents administration & dosage
Severe acute respiratory syndrome-related coronavirus drug effects
Severe Acute Respiratory Syndrome drug therapy
Subjects
Details
- Language :
- Russian
- ISSN :
- 0235-2990
- Volume :
- 56
- Issue :
- 7-8
- Database :
- MEDLINE
- Journal :
- Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]
- Publication Type :
- Academic Journal
- Accession number :
- 22359870